In this case series, patients reported: Rapid symptom relief (fatigue, brain fog, pain, GI symptoms) Improved dysautonomia and food tolerance Sustained benefit, even in non-obese, non-diabetic patients Minimal side effects at low doses Many experienced weight normalization due to reduced inflammation
Microdosing GLP-1 is not appropriate for individuals with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
As its full safety profile remains under investigation, the following reflects current available data and known class effects: Gastrointestinal symptoms are the most common: nausea, vomiting, diarrhoea, and constipation, particularly during dose escalation
This may further exaggerate the appearance of unevenness or creasing
Either way, this is a conversation to have with whoever is managing your prescription
SymptoGuard helps to manage the most common GLP-1 medication side effectsnausea, diarrhea, fatigue, and digestive discomfortwith our complete formula designed specifically for adults on medications like Ozempic, Wegovy, and Mounjaro
